Proteomics International Laboratories (ASX:PIQ)

Proteomics International Laboratories Limited (ASX:PIQ) is a medical technology company developing a range of predictive diagnostics and bio-analytical services that help medical professionals test for chronic diseases. The Company specialises in proteomics – the industrial scale study of the structure and function of proteins. Proteomics International’s aim is to use its expertise in proteins to develop and commercialise a suite of diagnostic tests for chronic diseases where there is unmet medical need.

Proteomics International is now implementing a stepped rollout of PromarkerD, its flagship diagnostic test for diabetic kidney disease, globally. Successful commercialisation of this diagnostic test is expected to bolster Proteomics’ revenue base. PromarkerD licensing fees and royalty payments will rise as the test is adopted by more physicians and licensed into new geographic regions. 

To learn more please visit: www.proteomics.com.au/